Poly adenosine diphosphate-ribose polymerase (PARP) inhibitors, a class of targeted anticancer therapies, prevent genetic ...
Further analysis of PARP10 mutants led the authors to the conclusion that PARP10 may be using a catalytic mechanism that distinguishes PARP10 from the classic PARPs and from other mARTs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback